Word

FIDALTO

Status

Dead

Status Code

606

Status Date

Monday, July 17, 2023

Serial Number

88728509

Mark Type

4000

Filing Date

Monday, December 16, 2019

Published for Opposition

Tuesday, April 21, 2020

Abandoned Date

Monday, July 17, 2023

Trademark Owner History

Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Trademark Events

Jul 17, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 17, 2023

Abandonment - No Use Statement Filed

Jan 5, 2023

Notice Of Approval Of Extension Request E-Mailed

Jan 4, 2023

Sou Extension 5 Granted

Dec 14, 2022

Sou Extension 5 Filed

Jan 4, 2023

Case Assigned To Intent To Use Paralegal

Dec 14, 2022

Teas Extension Received

Jun 17, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 15, 2022

Sou Extension 4 Granted

Jun 15, 2022

Sou Extension 4 Filed

Jun 15, 2022

Teas Extension Received

Dec 15, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 13, 2021

Sou Extension 3 Granted

Dec 13, 2021

Sou Extension 3 Filed

Dec 13, 2021

Teas Extension Received

Jun 17, 2021

Notice Of Approval Of Extension Request E-Mailed

Jun 15, 2021

Sou Extension 2 Granted

Jun 15, 2021

Sou Extension 2 Filed

Jun 15, 2021

Teas Extension Received

Dec 11, 2020

Notice Of Approval Of Extension Request E-Mailed

Dec 9, 2020

Sou Extension 1 Granted

Dec 9, 2020

Sou Extension 1 Filed

Dec 9, 2020

Teas Extension Received

Jun 16, 2020

Noa E-Mailed - Sou Required From Applicant

Apr 21, 2020

Official Gazette Publication Confirmation E-Mailed

Apr 21, 2020

Published For Opposition

Apr 1, 2020

Notification Of Notice Of Publication E-Mailed

Mar 16, 2020

Approved For Pub - Principal Register

Mar 16, 2020

Assigned To Examiner

Dec 19, 2019

New Application Office Supplied Data Entered

Dec 19, 2019

New Application Entered